piperaquine has been researched along with Asymptomatic Conditions in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, JM; Davis, TME; Kasian, B; Kong, C; Laman, M; Moore, BR; Mueller, I; Ome-Kaius, M; Robinson, LJ; Rogerson, S; Tobe, R; Yadi, G | 1 |
| De Smet, M; Dondorp, A; Etienne, W; Falq, G; Imwong, M; Kindermans, JM; Nguon, C; Rekol, H; Van Den Bergh, R | 1 |
| Affara, M; Badji, H; Bousema, T; Correa, S; D'Alessandro, U; Dabira, E; Di Tanna, GL; Drakeley, C; Gaye, A; Nwakanma, D; Okebe, J; Sanya-Isijola, F; Van Geertruyden, JP | 1 |
2 trial(s) available for piperaquine and Asymptomatic Conditions
| Article | Year |
|---|---|
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women.
Topics: Adult; Antimalarials; Asymptomatic Diseases; Azithromycin; Chemoprevention; Drug Combinations; Erythrocytes; Female; Gestational Age; Humans; Live Birth; Malaria, Falciparum; Malaria, Vivax; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pyrimethamine; Quinolines; Random Allocation; Severity of Illness Index; Stillbirth; Sulfadoxine | 2019 |
The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial.
Topics: Adolescent; Antimalarials; Artemisinins; Asymptomatic Diseases; Carrier State; Child; Drug Therapy, Combination; Female; Gambia; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Quinolines; Treatment Outcome | 2016 |
1 other study(ies) available for piperaquine and Asymptomatic Conditions
| Article | Year |
|---|---|
Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asymptomatic Diseases; Cambodia; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance; Female; Humans; Incidence; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Prevalence; Quinolines; Real-Time Polymerase Chain Reaction; Treatment Outcome; Young Adult | 2016 |